Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
Jinfeng Xiao(Wuhan University), Hongliang Li(Jiangnan University)
Cited by 39
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
|Cell Metabolism|2021|223
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
|Nature Medicine|2017|187
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
|Nature Communications|2016|182